Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients - Wikidata - wikimedia - TriplyDB

Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients

Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients

http://www.wikidata.org/entity/Q33627353

about

Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma Leukotriene-receptor antagonists versus placebo in the treatment of asthma in adults and adolescents: a systematic review and meta-analysis Stepping down from inhaled corticosteroids with leukotriene inhibitors in asthma: a systematic review and meta-analysis Recent advances in the management of asthma using leukotriene modifiers An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial Antileukotriene agents for the treatment of lung disease National Athletic Trainers' Association position statement: management of asthma in athletes.Role of Leukotrienes and Leukotriene Modifiers in Asthma.Long-term maintenance of pediatric asthma: focus on budesonide/formoterol inhalation aerosol.Effectiveness of montelukast administered as monotherapy or in combination with inhaled corticosteroid in pediatric patients with uncontrolled asthma: a prospective cohort study For and against. Should steroids be the first line treatment for asthma?Effects of antileukotrienes in the treatment of asthma.Anti-leukotrienes as add-on therapy to inhaled glucocorticoids in patients with asthma: systematic review of current evidence.Leukotriene-receptor antagonists. Role in asthma management.Montelukast: a review of its therapeutic potential in persistent asthma.Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma.Leukotriene receptor antagonist therapy Montelukast-associated Churg-Strauss vasculitis: another associated report.Clinical considerations in the use of inhaled corticosteroids for asthma.Leukotriene inhibitors and non-steroidal therapies in the treatment of asthma.Children with difficult asthma: a practical approach.The role of leukotriene receptor antagonists in the treatment of chronic asthma in childhood.Use of oral montelukast in the treatment of asthma.Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma.Combination therapy with inhaled long-acting beta2-agonists and inhaled corticosteroids: a paradigm shift in asthma management.Leukotriene receptor antagonists in the treatment of asthma: an update.Pharmacotherapy of patients with mild persistent asthma: strategies and unresolved issues.Management of asthma in adults: current therapy and future directions The linkage between Churg-Strauss syndrome and leukotriene receptor antagonists: fact or fiction?Combination therapy: appropriate for everyone?Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma Effects of inhaled corticosteroids, leukotriene receptor antagonists, or both, plus long-acting beta2-agonists on asthma pathophysiology: a review of the evidence.Leukotriene receptor antagonists--risks and benefits for use in paediatric asthma.Add-on therapy with montelukast or formoterol in patients with the glycine-16 beta2-receptor genotype Current and emerging nonsteroidal anti-inflammatory therapies targeting specific mechanisms in asthma and allergy.As-needed inhaled beta2-adrenoceptor agonists in moderate-to-severe asthma: current recommendations.

P2860

Q24197682-D59CCD6E-0BE8-4A47-B97B-DAF9F5B8A5B2 Q24247433-B95EE188-67B9-48E5-8561-459FF3B627DA Q24247489-6432FA3C-199C-49BC-B93C-37E9E31A790E Q26782714-1630CFF1-F9C8-4729-8D3F-0A47C0359F50 Q27022341-AB4D35CD-F9EC-4580-85B1-9E7AAEAE15FD Q28166742-D020894B-A20E-49B2-A9F7-D17442CB162D Q28189893-74AF595A-2FDF-4501-950F-E9BE47F0DB1D Q28192038-3871BF5D-A3B0-40BE-A4B2-8B42444CFDC1 Q28293842-95A7E233-A805-4650-8EC8-AE68ABDD78D1 Q28769235-4F17A546-8B8D-46CF-804A-0258DC6EF9CC Q33664150-AD5B9196-E474-4396-A805-A59C672E0DF8 Q33715425-50ABB950-6193-473B-B5A3-B121E724790C Q33755127-CAE3D4CE-4216-42DD-831D-92F4C2886977 Q33807137-1FBD3936-20CA-4FC1-AB25-0E9BC8EDE657 Q33836725-03191FC9-45E9-4DB6-AE4A-5B9196A724A0 Q33877940-93FAD206-D463-4C07-9F38-6ED9960942FE Q33903443-19EF96F2-2943-455A-9F1A-A26BDF62EBAC Q33914371-F39A1F61-06C3-4073-BFAF-DF9B73CB48A2 Q33978718-E1ABF807-198F-4761-BFA4-14C52B9FE77B Q34086351-0012FA87-71E3-4595-A94E-369F2D718B54 Q34109821-F53D1ACA-C59F-4100-B4EA-4881D9A71E77 Q34186812-1850BFA4-FD1B-4C2E-97D7-CAA0B2D3D5BF Q34240729-4F48F62D-A1E9-4C4A-B035-E94A50CB1A29 Q34273468-A7391665-0372-4D4A-ADDF-3933A539350F Q34291204-3DD6E278-0457-4CB2-A9F7-6299F55B7E62 Q34295593-93D7AF04-098A-4F82-B34A-A6541C180B9F Q34424227-2BA2B267-345A-482C-8230-39CED6F5B885 Q34523871-0E7003F0-6101-4FC6-BCBA-BFC55356E4BD Q34764665-B1658C9F-8F0F-4D01-B9F3-3916CB56642F Q35113606-3F3EAC2D-533B-46DC-8BD7-A08302C3F539 Q35143482-171343D7-28DE-46E8-9671-C2D971E4B42D Q35166699-4F05CF93-5670-4E4F-8C7B-0C0A69C972CF Q35180953-BFCA8D4A-ED0E-4AF1-9F26-96B81F3DF8E3 Q35535752-82342759-CE82-4E38-852C-D2E11C725EEA Q35535801-0DE1223B-6CE8-48D9-89D8-D4A59CB987B3 Q35675583-1BFCC1C8-A606-4943-9FD0-3A309A86F52F Q35779312-90928E02-EFEF-4114-BD67-BCD13DEC1ADF Q35825639-D5A90E64-2527-44AB-B744-3FE14BB6789A Q35879047-4AF90E94-657D-4300-8737-AC44DB53DAA0 Q36178737-63B9876E-4C13-42BC-BCA7-9DD869104B18

P2860

Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients

http://www.wikidata.org/entity/Q33627353

description

1999 nî lūn-bûn

@nan

1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Randomised, placebo controlled ...... steroids in asthmatic patients

@ast

Randomised, placebo controlled ...... steroids in asthmatic patients

@en

type

label

Randomised, placebo controlled ...... steroids in asthmatic patients

@ast

Randomised, placebo controlled ...... steroids in asthmatic patients

@en

prefLabel

Randomised, placebo controlled ...... steroids in asthmatic patients

@ast

Randomised, placebo controlled ...... steroids in asthmatic patients

@en

P1433

Q33627353-711C1915-DE63-4483-825D-BCDE7CC490D1

P1476

Q33627353-DE5AEA1F-FD38-433A-AD76-39D914C41176

P2093

Q33627353-02CC3BE8-E065-45E2-B9A9-DA4602C524CC

Q33627353-137DA17A-29EF-45EA-9D3D-32921690025C

Q33627353-38BE6111-D5E4-4387-879B-45D85C822859

Q33627353-39619365-D74F-4786-A014-C309FD7593B0

Q33627353-4CBA4F8A-EB7E-4A6F-9457-63FEF778B7BB

Q33627353-7D2A26C9-F4D1-4C2B-AE4D-C6657F3C0CDD

Q33627353-80D54E62-7866-4DB8-876C-D5E7576CAD2D

Q33627353-8BA587FE-5971-45BD-9CD9-42D92957B34D

Q33627353-BE29A75B-790A-4948-9D36-2CBB83808F6E

Q33627353-F18A9D22-96B1-4D5D-9CF2-E663DB8F95A6

P2860

Q33627353-11D91B29-313C-4181-8319-D9FC4C3DF06F

Q33627353-1731B21E-60C5-44D3-BEA0-2EA0744A4DC0

Q33627353-216A86EC-5EB9-4EBC-ACD3-B7E8C8808024

Q33627353-25F660A4-88C4-4571-BCA4-D0C4A6CEBC86

Q33627353-658A6D6C-65CF-45C7-8391-312FB7F86958

Q33627353-9C01EBAC-ED14-4018-8E3D-3DF8539F5C64

Q33627353-9E461B62-5938-4989-BA8B-8849F3A3F811

Q33627353-B2080887-5E7B-4D21-941B-608CAC151FC5

Q33627353-CD82D484-CF29-41CE-95B2-A76E04F016A0

Q33627353-E0D5AC01-9C18-4C2F-A6DE-737F6C9BDBAA

P304

Q33627353-A98EE849-AC9E-4DE1-A07C-B85FDB4572AC

P31

Q33627353-B0E57614-EC93-44C9-868F-8D645FB4E5FC

P356

Q33627353-07885AE7-DA42-49DC-9318-53B50675D5BC

P407

Q33627353-B9482306-B711-4CB1-94D0-229DCF87DC61

P433

Q33627353-5CA6513B-11D8-4C8D-8A39-7E94F7A74DC4

P478

Q33627353-96F33C64-894B-486C-97C9-67CE91388EB2

P577

Q33627353-A41DE66C-340D-4733-ACCC-12A4A1500784

P5875

Q33627353-ED7E6296-948B-438E-8090-E4D98C159DC8

P698

Q33627353-1C3C8380-C81D-496E-B86A-30467F6C632A

P921

Q33627353-1DDC0061-B5C6-4F8B-9F9A-0D7CB5590B45

Q33627353-F117045F-373D-4A0F-9420-CFA6A7D091B0

P932

Q33627353-94E5C44F-3CA5-4A0B-8D7C-AFF000453910

P356

BMJ.319.7202.87

P1433

P1476

Randomised, placebo controlled ...... steroids in asthmatic patients

@en

P2093

A F Finn

http://www.w3.org/2001/XMLSchema#string

B C Seidenberg

http://www.w3.org/2001/XMLSchema#string

C G Löfdahl

http://www.w3.org/2001/XMLSchema#string

E Israel

http://www.w3.org/2001/XMLSchema#string

J A Leff

http://www.w3.org/2001/XMLSchema#string

M J Noonan

http://www.w3.org/2001/XMLSchema#string

P Godard

http://www.w3.org/2001/XMLSchema#string

S Kundu

http://www.w3.org/2001/XMLSchema#string

T Capizzi

http://www.w3.org/2001/XMLSchema#string

T F Reiss

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

Standardization of Spirometry, 1994 Update. American Thoracic Society

Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids

Use of inhaled corticosteroids and the risk of cataracts.

Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network.

Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 cells.

Efficacy and safety of inhaled corticosteroids. New developments.

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

Lack of benefit of methotrexate in severe, steroid-dependent asthma. A double-blind, placebo-controlled study.

Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.

P304

87-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.319.7202.87

http://www.w3.org/2001/XMLSchema#string

P407

P433

7202

http://www.w3.org/2001/XMLSchema#string

P478

319

http://www.w3.org/2001/XMLSchema#string

P577

1999-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12899941

http://www.w3.org/2001/XMLSchema#string

P698

10398629

http://www.w3.org/2001/XMLSchema#string

P921

P932

28156

http://www.w3.org/2001/XMLSchema#string